This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing Nerandomilast in IPF following the publication in NEJM
Ticker(s): BOEHRINGER INGELHEIMWho's the expert?
Institution - Hannibal Clinic
- Specializes in Critical Care Medicine, Internal Medicine, Pulmonary Disease and Sleep Medicine.
- Manages treatment for ~2000 patients with severe asthma.
- Familiar with the literature and use of Airsupra
Interview GoalDiscuss the publication of phase 3 data of nerandomilast and how it may fit into the treatment algorithm
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
